Metraipolis › archive › dc_75d5990de883

Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach — Europe PMC PMID:41472282

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41472282
DOI: 10.3390/v17121613
License (as archived): solo-consultazione
Archived: 2026-11-07T16:05:59.208Z
SHA-256 of the archived text: 271b6f9b1941e0b26f406590f3d96148a13cd9c560b73c14b79edcab675e7341
Stable URL of this page: https://metraipolis.com/documento/dc_75d5990de883

How to cite

Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach — Europe PMC PMID:41472282 — Europe PMC (en), https://europepmc.org/article/MED/41472282 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_75d5990de883 (Metraipolis archive dc_75d5990de883, sha256 271b6f9b1941e0b26f406590f3d96148a13cd9c560b73c14b79edcab675e7341)

BibTeX

@misc{dc75d5990de883,
  title = {Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach — Europe PMC PMID:41472282},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41472282},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_75d5990de883; sha256 271b6f9b1941e0b26f406590f3d96148a13cd9c560b73c14b79edcab675e7341},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41472282. Agents can read the archived copy with the MCP tool read_document.